Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies.
about
Revisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study.Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trialRelapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.
P2860
Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Phase II trial of cladribine a ...... fractory myeloid malignancies.
@en
Phase II trial of cladribine a ...... fractory myeloid malignancies.
@nl
type
label
Phase II trial of cladribine a ...... fractory myeloid malignancies.
@en
Phase II trial of cladribine a ...... fractory myeloid malignancies.
@nl
prefLabel
Phase II trial of cladribine a ...... fractory myeloid malignancies.
@en
Phase II trial of cladribine a ...... fractory myeloid malignancies.
@nl
P2093
P1433
P1476
Phase II trial of cladribine a ...... fractory myeloid malignancies.
@en
P2093
Bassem I Razzouk
Deo Kumar Srivastava
Jeffrey E Rubnitz
Raul C Ribeiro
Victor M Santana
P304
P356
10.1016/J.LEUKRES.2003.08.010
P577
2004-04-01T00:00:00Z